Irukandji syndrome: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
Irukandji Syndrome<ref> Hauglid, C., Kiel, J., & Schmidt, A. (2021, April 23). Emergen-Sea Medicine: Overview of Marine Envenomations - Page 4 of 5. ACEP Now. https://www.acepnow.com/article/emergen-sea-medicine-overview-of-marine-envenomations/4/.</ref>
Background<ref> Hauglid, C., Kiel, J., & Schmidt, A. (2021, April 23). Emergen-Sea Medicine: Overview of Marine Envenomations - Page 4 of 5. ACEP Now. https://www.acepnow.com/article/emergen-sea-medicine-overview-of-marine-envenomations/4/.</ref>
*Usually develops within 2 hours of envenomation & can last up to 2 days
*Usually develops within 2 hours of envenomation & can last up to 2 days
*Rare but potentially fatal complication can manifest in diverse ways:
*Rare but potentially fatal complication can manifest in diverse ways:

Revision as of 00:18, 22 July 2021

Background[1]

  • Usually develops within 2 hours of envenomation & can last up to 2 days
  • Rare but potentially fatal complication can manifest in diverse ways:
    • Myalgias
    • Back pain
    • Chest pain
    • Abdominal pain
    • Nausea and vomiting
    • Diaphoresis
    • Hypertensive crisis
    • Cardiogenic pulmonary edema
    • Intracranial hemorrhage
    • Death
  1. Hauglid, C., Kiel, J., & Schmidt, A. (2021, April 23). Emergen-Sea Medicine: Overview of Marine Envenomations - Page 4 of 5. ACEP Now. https://www.acepnow.com/article/emergen-sea-medicine-overview-of-marine-envenomations/4/.